Healthcare Stocks Top News Skye Completes $17M Financing and Acquires Novel Phase 2-Ready CB1-Inhibiting Monoclonal Antibody Acquisition of Bird Rock Bio builds Skye’s position as a leading endocannabinoid… Ryan AllwayAugust 21, 2023